| abstract |
The present invention relates to a pharmaceutical composition for preventing, ameliorating or treating obesity and liver disease, comprising an ester and an acid anhydride compound, or a pharmaceutically acceptable salt thereof, wherein the compound represented by Formula 1 according to the present invention is STAMP2 expressed. Since it is excellent in the effect of inhibiting fat production by increasing the obesity, non-alcoholic fatty liver disease, liver cancer can be usefully used to prevent, improve or treat. |